메뉴 건너뛰기




Volumn 61, Issue 9, 2015, Pages 1191-1196

Diagnostic accuracy of noninvasive genotyping of EGFR in lung cancer patients by deep sequencing of plasma cell-free DNA

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING TUMOR DNA; DNA; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR;

EID: 84942519785     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.241414     Document Type: Article
Times cited : (97)

References (23)
  • 1
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3    Gurubhagavatula, S.4    Okimoto, R.A.5    Brannigan, B.W.6
  • 2
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
    • Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.G.1    Janne, P.A.2    Lee, J.C.3    Tracy, S.4    Greulich, H.5    Gabriel, S.6
  • 4
    • 35548962203 scopus 로고    scopus 로고
    • Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer
    • Mitsudomi T, Yatabe Y. Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci 2007;98:1817-24.
    • (2007) Cancer Sci , vol.98 , pp. 1817-1824
    • Mitsudomi, T.1    Yatabe, Y.2
  • 6
    • 18244371651 scopus 로고    scopus 로고
    • Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    • Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005;2:e73.
    • (2005) PLoS Med , vol.2 , pp. e73
    • Pao, W.1    Miller, V.A.2    Politi, K.A.3    Riely, G.J.4    Somwar, R.5    Zakowski, M.F.6
  • 7
    • 84921032852 scopus 로고    scopus 로고
    • Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: A meta-analysis
    • Qiu M, Wang J, Xu Y, Ding X, Li M, Jiang F, et al. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2015;24:206-12.
    • (2015) Cancer Epidemiol Biomarkers Prev , vol.24 , pp. 206-212
    • Qiu, M.1    Wang, J.2    Xu, Y.3    Ding, X.4    Li, M.5    Jiang, F.6
  • 8
    • 66849091226 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer
    • Bai H, Mao L, Wang HS, Zhao J, Yang L, An TT, et al. Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer. J Clin Oncol 2009;27:2653-9.
    • (2009) J Clin Oncol , vol.27 , pp. 2653-2659
    • Bai, H.1    Mao, L.2    Wang, H.S.3    Zhao, J.4    Yang, L.5    An, T.T.6
  • 9
    • 79957767374 scopus 로고    scopus 로고
    • Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
    • Brevet M, Johnson ML, Azzoli CG, Ladanyi M. Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors. Lung Cancer 2011;73:96-102.
    • (2011) Lung Cancer , vol.73 , pp. 96-102
    • Brevet, M.1    Johnson, M.L.2    Azzoli, C.G.3    Ladanyi, M.4
  • 10
    • 34548593298 scopus 로고    scopus 로고
    • Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)
    • Kimura H, Suminoe M, Kasahara K, Sone T, Araya T, Tamori S, et al. Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). Br J Cancer 2007;97:778-84.
    • (2007) Br J Cancer , vol.97 , pp. 778-784
    • Kimura, H.1    Suminoe, M.2    Kasahara, K.3    Sone, T.4    Araya, T.5    Tamori, S.6
  • 11
    • 81855208762 scopus 로고    scopus 로고
    • Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas
    • Taniguchi K, Uchida J, Nishino K, Kumagai T, Okuyama T, Okami J, et al. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin Cancer Res 2011;17:7808-15.
    • (2011) Clin Cancer Res , vol.17 , pp. 7808-7815
    • Taniguchi, K.1    Uchida, J.2    Nishino, K.3    Kumagai, T.4    Okuyama, T.5    Okami, J.6
  • 13
    • 84896737232 scopus 로고    scopus 로고
    • Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data
    • Kukita Y, Uchida J, Oba S, Nishino K, Kumagai T, Taniguchi K, et al. Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data. PLoS One 2013;8:e81468.
    • (2013) PLoS One , vol.8
    • Kukita, Y.1    Uchida, J.2    Oba, S.3    Nishino, K.4    Kumagai, T.5    Taniguchi, K.6
  • 14
    • 79960597679 scopus 로고    scopus 로고
    • An integrated semiconductor device enabling non-optical genome sequencing
    • Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011;475:348-52.
    • (2011) Nature , vol.475 , pp. 348-352
    • Rothberg, J.M.1    Hinz, W.2    Rearick, T.M.3    Schultz, J.4    Mileski, W.5    Davey, M.6
  • 15
    • 23844465454 scopus 로고    scopus 로고
    • Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
    • Nagai Y, Miyazawa H, Huqun, Tanaka T, Udagawa K, Kato M, et al. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 2005;65:7276-82.
    • (2005) Cancer Res , vol.65 , pp. 7276-7282
    • Nagai, Y.1    Miyazawa, H.2    Huqun3    Tanaka, T.4    Udagawa, K.5    Kato, M.6
  • 16
    • 0032377357 scopus 로고    scopus 로고
    • Approximate is better than 'exact' for interval estimation of binomial proportions
    • Agresti A, Coull BA. Approximate is better than 'exact' for interval estimation of binomial proportions. American Statistician 1998;52:119-26.
    • (1998) American Statistician , vol.52 , pp. 119-126
    • Agresti, A.1    Coull, B.A.2
  • 17
    • 33748074447 scopus 로고    scopus 로고
    • Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer
    • Inukai M, Toyooka S, Ito S, Asano H, Ichihara S, Soh J, et al. Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. Cancer Res 2006;66:7854-8.
    • (2006) Cancer Res , vol.66 , pp. 7854-7858
    • Inukai, M.1    Toyooka, S.2    Ito, S.3    Asano, H.4    Ichihara, S.5    Soh, J.6
  • 19
    • 84864045330 scopus 로고    scopus 로고
    • EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas
    • Chen ZY, Zhong WZ, Zhang XC, Su J, Yang XN, Chen ZH, et al. EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas. Oncologist 2012;17:978-85.
    • (2012) Oncologist , vol.17 , pp. 978-985
    • Chen, Z.Y.1    Zhong, W.Z.2    Zhang, X.C.3    Su, J.4    Yang, X.N.5    Chen, Z.H.6
  • 20
    • 84887497121 scopus 로고    scopus 로고
    • The quest to overcome resistance to EGFR-targeted therapies in cancer
    • Chong CR, Janne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med 2013;19:1389-400.
    • (2013) Nat Med , vol.19 , pp. 1389-1400
    • Chong, C.R.1    Janne, P.A.2
  • 22
    • 84863000299 scopus 로고    scopus 로고
    • The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
    • Diaz LA Jr, Williams RT, Wu J, Kinde I, Hecht JR, BerlinJ, et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 2012;486:537-40.
    • (2012) Nature , vol.486 , pp. 537-540
    • Diaz, L.A.1    Williams, R.T.2    Wu, J.3    Kinde, I.4    Hecht, J.R.5    Berlin, J.6
  • 23
    • 84906250256 scopus 로고    scopus 로고
    • Gefitinib treatment in EGFR mutated Caucasian NSCLC: Circulating-free tumor DNA as a surrogate for determination of EGFR status
    • Douillard JY, Ostoros G, Cobo M, Ciuleanu T, Cole R, McWalter G, et al. Gefitinib treatment in EGFR mutated Caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status. J Thorac Oncol 2014;9:1345-53.
    • (2014) J Thorac Oncol , vol.9 , pp. 1345-1353
    • Douillard, J.Y.1    Ostoros, G.2    Cobo, M.3    Ciuleanu, T.4    Cole, R.5    McWalter, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.